Shape-Changing IOL Shows Durability - Summary - MDSpire
Clinical Guidelines

Shape-Changing IOL Shows Durability

Atia Vision reports positive 36-month data for its shape-changing IOL at ASCRS 2026

  • April 28, 2026

  • 3 min

Share

Atia Vision has presented promising three-year data on its investigational OmniVu Lens System, demonstrating stable refractive outcomes and extensive visual clarity post-implantation. The data, showcased by Dr. William F. Wiley at the 2026 ASCRS Annual Meeting, revealed that mean manifest refraction remained stable, with excellent visual acuity results, indicating its potential in enhancing cataract surgery. The innovative design aims to adapt to the eye's natural accommodation. While currently investigational, it has received FDA IDE approval for a US feasibility study.

Original Source(s)

Shape-Changing IOL Shows Durability

  • April 28, 2026

Related Content

Inside the Aging Eye

A comprehensive new Elsevier publication brings global expertise together to unpack how aging drives ocular structure, function, and disease

  • April 28, 2026

  • 2 min
Keeping an Eye on Diabetes

Progress, pitfalls and the future of the UK’s Diabetic Eye Screening Program

Seeing the Halo

Researchers evaluate a novel optical phenomenon that could expand the clinical value of slit-lamp examination in keratoconus

  • April 27, 2026

  • 3 min